Aleen Inc. Advances Development of Smart Analytics Feature
Toronto, Ontario--(Newsfile Corp. - December 2, 2025) - Aleen Inc. (CSE: ALEN.U), a digital wellness company, continues its structured path from early exploration and user testing to personal account development, and now moves into full-scale creation of its Smart Analytics feature. Designed to help users interpret their wellness data clearly and responsibly, Smart Analytics transforms raw information into structured, accessible insights. The system emphasizes transparency and personal
2025-12-02 8:00 AM EST | Aleen Inc.
Delota Reports Financial Results for the Three and Six Months Ended September 30, 2025
Highlights: Total revenue of $8.7 million for the Three Months Ended 2026 Total System-Wide Revenue of $10.4 million for the Three Months Ended 2026 31% gross profit margin for the Three Months Ended 2026 Total revenue of $18.7 million for the Six Months Ended 2026 Total System-Wide Revenue of $21.0 million for the Six Months Ended 2026 34% gross prof
Retail, Cannabis, Health, Cannabis Dispensary
2025-12-02 7:30 AM EST | Delota Corp.
Cheelcare to Represent Canadian Health Innovation at Health Tech Forward 2025 in Barcelona
Toronto, Ontario--(Newsfile Corp. - December 2, 2025) - Cheelcare (TSXV: CHER), a Canadian innovator in advanced mobility solutions, was selected to participate in a Canadian trade mission to Barcelona, Spain, from December 2-4, 2025. As part of this mission, Eugene Cherny, CEO of Cheelcare, will present during the "Active Mobility Innovation - Startup Pitches" at the prestigious Health Tech Forward 2025 Conference, showcasing Cheelcare's cutting-edge assistive mobility technology, inc
2025-12-02 7:00 AM EST | Cheelcare Inc.
FendX Provides Corporate Update
Vancouver, British Columbia--(Newsfile Corp. - December 1, 2025) - FendX Technologies Inc. (CSE: FNDX) (OTCQB: FDXTF) (FSE: E8D0) (the "Company" or "FendX"), an innovative surface protection company developing technology-based solutions to reduce the spread of harmful pathogens, announces the completion of its previously disclosed debt settlement from November 21, 2025. The Company issued 34,540 common shares (each, a "Share") at $0.74 per Share to settle $25,560 of debt
Technology, Healthcare and Hospitals, Health
2025-12-01 6:15 PM EST | FendX Technologies Inc.
Numinus Wellness Provides Corporate Update
Vancouver, British Columbia--(Newsfile Corp. - December 1, 2025) - Numinus Wellness Inc. (TSX: NUMI) (OTCQX: NUMIF) ("Numinus" or the "Company"), a mental health care company focused on innovative behavioral health treatments with a focus on safe, evidence-based psychedelic-assisted therapies, is providing a corporate update. Change of auditors On October 10, 2025, the Company announced that Davidson & Company LLP ("Davidson") had resigned as the Company's i
2025-12-01 5:00 PM EST | Numinus Wellness Inc.
Red Light Holland Reports Second Quarter 2026 Results and Provides Corporate Update
Toronto, Ontario--(Newsfile Corp. - December 1, 2025) - Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX) (OTCQB: TRUFF) ("Red Light Holland" or the "Company"), an Ontario-based corporation engaged in the production, growth, and sale of functional mushrooms, mushroom home grow kits in North America and Europe, and a premium brand of psilocybin truffles to the legal recreational market within the Netherlands, in compliance with all applicable laws, announces its financial and operat
Cannabis, Health, Psychedelics, Cannabis Ancillary Service Provider
2025-12-01 4:30 PM EST | Red Light Holland Corp.
Adia Med Partners with America's #1 Health Talk Show Host, Dr. Asa Andrew, to Bring Breakthrough Stem Cell Therapies to the Spotlight
Winter Park, Florida--(Newsfile Corp. - December 1, 2025) - Adia Nutrition Inc. (OTCQB: ADIA), one of the nation's leaders in Stem Cell Technology is excited to announce a partnership with 3X Physician and Multi-Platform Media talk show personality Dr. Asa Andrew (known to his fans as Doctor Asa).
Healthcare and Hospitals, Health
2025-12-01 9:30 AM EST | Adia Nutrition Inc.
Senior Care Authority Highlights Urgent Need for Proactive Driving-Safety Conversations as Older Driver Awareness Week Begins
Incline Village, Nevada--(Newsfile Corp. - December 1, 2025) - Today marks the start of Older Driver Awareness Week, Dec. 1-5, and Senior Care Authority, a national eldercare consulting and senior living placement company, is encouraging families to begin proactive conversations about driving safety with aging loved ones before a crisis forces the issue. According to
Healthcare and Hospitals, Health
2025-12-01 8:00 AM EST | Senior Care Authority
New Data from the Phase II ARCHER Trial Demonstrate CardiolRx(TM) Improves Heart Structure in Patients with Acute Myocarditis, Supporting Expansion Across Inflammatory Cardiac Conditions
Phase II ARCHER trial showed a significant reduction in left ventricular (LV) mass (p=0.0117) and improvements in multiple key cardiac MRI (CMR) measures of structural heart recovery in patients with acute myocarditis. Results provide clinical evidence that CardiolRx™ reduces inflammation-driven structural damage in the heart, an important cause of heart failure progression. The ARCHER data strengthen
Biotechnology, Cannabis, Health, Cannabis Manufacturer
2025-12-01 7:27 AM EST | Cardiol Therapeutics Inc.
Rapid Dose Announces Extension to Promissory Notes
Burlington, Ontario--(Newsfile Corp. - November 28, 2025) - Rapid Dose Therapeutics Corp. (CSE: DOSE) ("RDT" or the "Company") announced today that it intends to extend the maturity date of its outstanding secured convertible notes (the "Notes") previously issued on its private placement financing (the "Financing") which closed in 2023. The Notes have a maturity date of November 30, 2025, and the Company intends to extend the maturity date for one year, t
2025-11-28 8:14 PM EST | Rapid Dose Therapeutics Corp.
Promino Nutritional Sciences Inc. Announces Revocation of Cease Trade Order
Burlington, Ontario--(Newsfile Corp. - November 27, 2025) - Promino Nutritional Sciences Inc. (CSE: MUSL) (OTCID: MUSLF) (FSE: 93X) (the "Company" or "Promino") is pleased to announce the full revocation of a Failure-to-File Cease Trade Order (the "FFCTO") issued by the Ontario Securities Commission (the "OSC") effective on November 26, 2025. The FFCTO prohibited the trading by any person or company of any securities of the Company in Canada, except pursuant to limited exceptio
Food / Beverages, Sports, Health
2025-11-27 2:47 PM EST | Promino Nutritional Sciences, Inc.
Psyched Wellness Launches Calmer, a 2x Version of Calm and an Enhanced Flavour Profile for Calm
Toronto, Ontario--(Newsfile Corp. - November 27, 2025) - Psyched Wellness Ltd. (CSE: PSYC) (OTCQB: PSYCF) (FSE: 5U9) (the "Company" or "Psyched"), a life sciences company specializing in the production and distribution of dietary supplements derived from the Amanita Muscaria mushroom, is pleased to announce the launch of Calmer, a new product offering that delivers twice the potency of its flagship product, Calm. The Company has also enhanced the flavour profile of Calm in
Cannabis, Health, Psychedelics, Cannabis Manufacturer
2025-11-27 7:30 AM EST | Psyched Wellness Ltd.
Edison Issues Report on Percheron Therapeutics (PER)
London, United Kingdom--(Newsfile Corp. - November 27, 2025) - Edison issues report on Percheron Therapeutics (ASX: PER) We have refreshed our investment case for Percheron as the company heads into CY26 with a clearly defined Phase II plan for HMBD-002, backed by positive Phase I data and a strengthened management team. Our model now reflects the likely Phase II basket design, comprising exploratory and subsequent expansion cohorts, along with refined assumptions on study size, sequenc
Banking / Financial Services, Computer Hardware, Computer Software, Health
2025-11-27 3:16 AM EST | Edison Group
MyndTec Inc. Announces Resignation of Director
Mississauga, Ontario--(Newsfile Corp. - November 26, 2025) - MyndTec Inc. (CSE: MYTC) ("MyndTec" or the "Company"), a neurological treatment and rehabilitation medical technology company, today announced that P. Harvey Griggs has resigned from the Company's Board of Directors, effective November 26, 2025, for personal reasons to focus on his health. Dr. Griggs served as a director of MyndTec for six years and was an early investor in the Company. "On behalf of the Boa
Technology, Healthcare and Hospitals, Health
2025-11-26 5:30 PM EST | MyndTec Inc.
TempraMed Signs Exclusive Distribution Agreement with Leading Consumer Health Distributor in Israel
Leading distributor of global companies including GSK/Haleon, Cargill, Reynolds, Paskesz Guri distributes reputable brands including Sensodyne, Aquafresh, Parodontax, Truvia, Diamond and more Strategic agreement supports TempraMed's global shift from online B2C to major pharmacy networks and B2B medical payers Distribution to over 2,500 outlets including pharmacy chains, supermarkets, HMOs and independent pha
Technology, Biotechnology, Pharmaceuticals, Health
2025-11-26 4:51 PM EST | TempraMed Technologies Ltd
Hemostemix Starts its Roll-up of Cardiology Practices, Acquiring its First Two
Calgary, Alberta--(Newsfile Corp. - November 26, 2025) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0), is pleased to announce a binding Letter of Intent for the acquisition of the first two cardiology practices under the Company's clinic roll-up and commercialization strategy. The practices of Dr. Roberto Manuel Fernandez-de-Castro and Dr. Hector Rosario Figueroa, two of the Dominican Republic's most respected interventional cardiologists, will be acquired by Hemostemi
Biotechnology, Pharmaceuticals, Health
2025-11-26 4:21 PM EST | Hemostemix Inc.
DiagnosTear Technologies Announces Initiation of a Collaboration with LV Prasad Eye Institute for Advancing the Clinical Validation of TeaRx(TM) Red Eye Diagnostic Test
Vancouver, British Columbia--(Newsfile Corp. - November 26, 2025) - DiagnosTear Technologies Inc. (CSE: DTR) ("DiagnosTear" or the "Company"), a leader in developing cutting-edge point-of-care eye diagnostic solutions, is pleased to announce its scientific collaboration with the renowned LV Prasad Eye Institute (LVPEI) in Hyderabad, India. The partnership supports the clinical validation of TeaRx™, the Company's next-generation Red Eye diagnostic test. DiagnosTear is currently dev
2025-11-26 4:15 PM EST | DiagnosTear Technologies Inc.
Optimi Health to Supply MDMA to MAPS Israel's Clinical Trial for Trauma-Related PTSD
Vancouver, British Columbia--(Newsfile Corp. - November 26, 2025) - Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FSE: 8BN) ("Optimi" or the "Company"), a Canadian manufacturer of pharmaceutical-grade psychedelics, including MDMA and naturally derived psilocybin, has been selected to supply the MDMA capsules for MAPS Israel's Healing October 7th project, which includes a clinical trial for Post-Traumatic Stress Disorder (PTSD) that has received formal approval from the Israeli
Biotechnology, Pharmaceuticals, Health, Psychedelics
2025-11-26 7:00 AM EST | Optimi Health Corp.
PreveCeutical Medical and BioGene Therapeutics Announce Closing of Plan of Arrangement
Vancouver, British Columbia--(Newsfile Corp. - November 26, 2025) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the "Company" or "PreveCeutical") and BioGene Therapeutics Inc. ("BioGene"), are pleased to announce that, further to its News Releases of September 4, 2025, September 19, 2025, October 10, 2025, Oc
Biotechnology, Pharmaceuticals, Health
2025-11-26 7:00 AM EST | PreveCeutical Medical Inc.
Edison Issues Report on Faraday Future Intelligent Electric (FFAI)
London, United Kingdom--(Newsfile Corp. - November 26, 2025) - Edison issues report on Faraday Future Intelligent Electric (NASDAQ: FFAI). Faraday Future Intelligent Electric (NASDAQ: FFAI) is expanding its strategy beyond being a luxury electric vehicle (EV) pioneer to include an asset-light, partnership-led production model. Its vehicle differentiation is based on an AI-powered mobility ecosystem using proprietary software. Its current focus is on product delivery and sales execution,
Banking / Financial Services, Computer Hardware, Computer Software, Health
2025-11-26 5:18 AM EST | Edison Group